Information was received from a manufacturer representative regarding a patient who was implanted with an implantable neurostimulator (ins) for non-malignant pain.Caller is with the pt and notes that since implant, the pt has had trouble charging.The caller states that the pt uses adhesive discs and she puts any pressure at all on the antenna over the ins she loses coupling from 8 to 0 boxes.The rep had a spare ins recharger (insr) and was able to replicate this with the spare insr.Pt states she can't lean back, has to walk with the antenna loose connected to the adhesive disc and it is painful and uncomfortable.The pt states that she had to charge for 7 hours to get from 0-100% (flashing last quartile) yesterday.The caller notes the ins in the pocket has a slight tilt.Tss reviewed based on caller's info it is unlikely that replacing product will resolve the issue.The caller notes the will look at pocket but ultimately may look at replacement soon.Additional information was received from the rep, it was reported that appt scheduled for (b)(6) 2021 with neurosurgery p.A.The issue was not resolved.No explant scheduled at this time.
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|